Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
50 Leser
Artikel bewerten:
(0)

Express Scripts Completes Spinoff of Rx Outreach / New nonprofit addresses growing medical needs of low-income Americans

ST. LOUIS, Oct. 5 /PRNewswire/ -- Express Scripts has completed the spinoff of its Rx Outreach business unit to create a new independent, nonprofit charitable organization with the mission of improving access to prescription medicines for low-income, uninsured Americans and working families.

Michael Holmes, former executive vice president of Express Scripts, leads the new national organization, which has its headquarters in St. Louis.

George Paz, chairman, president and chief executive officer of Express Scripts, said, "Rx Outreach has an important mission in assisting deserving Americans in obtaining better access to the safe and affordable drugs they need. I am pleased that Michael Holmes is heading this independent organization and confident that under his leadership it will perform a significant social good."

Rx Outreach's new structure as a nonprofit will enable public, charitable and private entities, including Express Scripts, to work together to bring appropriate drug therapies to those who have limited or no access today. The opportunity to develop expanded partnerships with branded and generic pharmaceutical manufacturers, community health centers, rural and frontier clinics, and faith-based charities will allow Rx Outreach the potential to offer a broader level of service.

Holmes noted the challenges ahead. "During tough economic times, the need for an organization like ours is especially acute, but we know that private resources are stretched thin," he said. "We applaud Express Scripts setting us on the road to independence, and we readily accept the challenge of building new partnerships and support for accomplishing our critical mission."

Express Scripts announced the spinoff in January and has supported Rx Outreach during the transition period.

About Express Scripts

Express Scripts, Inc., one of the largest pharmacy benefit management companies in North America, is leading the way toward creating better health and value for patients through Consumerology®, the advanced application of the behavioral sciences to healthcare. This approach is helping millions of members realize greater healthcare outcomes and lowering cost by assisting in influencing their behavior. Headquartered in St. Louis, Express Scripts provides integrated PBM services including network-pharmacy claims processing, home delivery services, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. More information can be found at http://www.express-scripts.com/ and http://www.consumerology.com/.

About Rx Outreach

Rx Outreach is a nonprofit charitable organization with the mission of providing medications to people in need. Rx Outreach envisions that all individuals will have access to affordable medications to preserve their quality of health. Headquartered in St. Louis, Rx Outreach provides nationwide access to a broad range of prescription drugs for low-income families through a dedicated staff of pharmacy professionals and a highly automated home delivery system. More information can be found at http://www.rxoutreach.org/.

Media Contacts: Thom Gross 314.684.6321 RTGross@express-scripts.com Marsha England 314.627.6100 Marsha.england@rxoutreach.org

Express Scripts

CONTACT: Thom Gross of Express Scripts, +1-314-684-6321,
RTGross@express-scripts.com, or Marsha England of Rx Outreach,
+1-314-627-6100, Marsha.england@rxoutreach.org

Web Site: http://www.express-scripts.com/
http://www.rxoutreach.org/

© 2010 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.